Cardiac resynchronization therapy: Overcoming ventricular dyssynchrony in dilated heart failure

Cardiology in Review

Volumn 11, Issue 4, 2003, Pages 221-239

  Kerwin, Walter F ^a,b   Paz, Offir ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIOVENTRICULAR BLOCK; CONGESTIVE HEART FAILURE; HEART CONDUCTION; HEART FUNCTION; HEART LEFT VENTRICLE FILLING PRESSURE; HEART PACING; HEART VENTRICLE ENDDIASTOLIC PRESSURE; REVIEW;

EID: 0037778762     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CRD.0000078444.96998.99     Document Type: Review

References (62)

1. Bristow MB. Adrenergic receptor blockade in chronic heart failure. Circulation 2000;101:558-569.
2. The CONSENSUS Trial Study Group. Effect of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-1435.
3. Pitt B, Zannad F, Remme WJ, et al. For the Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on mortality and morbidity in patients with severe heart failure. N Engl J Med 1999;341:709-717.
4. Baldasseroni S, Opasich C, Gorini M, et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J 2002 Mar;143:398-405.
5. Stevenson WG, Stevenson LW, Middelkauff HR, et al. Improving survival for patients with atrial fibrillation in advanced heart failure. J Am Coll Cardiol 1996;28:1458-1463.
6. Schoeller R, Andersen D, Buttner P, et al. First- or second-degree atrioventricular block as a risk factor in idiopathic dilated cardiomyopathy. Am J Cardiol 1993;71:720-726.
7. Shamim W, Francis DP, Yousufuddin M, et al. Intraventricular conduction delay: a prognostic marker in chronic heart failure. Int J Cardiol 1999;70:171-178.
8. Shenkman HJ, Pampati V, Khadelwal AK, et al. Congestive heart failure and QRS duration: establishing prognosis study. Chest 2002;122:528-534.
9. Silvet H, Amnin J, Padmanabhan S, et al. Prognostic implications of increased QRS duration in patients with moderate and severe left ventricular systolic dysfunction. Am J Cardiol 2001;88:182-184.
10. Bramlet DA, Morris KG, Coleman RE, et al. Effect of rate-dependent left bundle branch block on global and regional left ventricular function. Circulation 1983;67:1059-1065.
11. Grines CL, Bashore TM, Boudoulas H, et al. Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony Circulation 1989;79:845-853.
12. Xiao HB, Lee CH, Gibson DG. Effect of left bundle branch block on diastolic function in dilated cardiomyopathy. Br Heart J 1991;66:443-447.
13. Xiao HB, Brecker SJ, Gibson DG. Effects of abnormal activation on the time course of left ventricular pulse in dilated cardiomyopathy. Br Heart J 1992;68:403-407.
14. Frais MA, Botvinick EH, Shosa DW, et al. Phase image characterization of ventricular contraction in left and right bundle branch block. Am J Cardiol 1982;50:95-105.
15. Frais M, Botvinick E, O'Connell W, et al. Phase image characterization of localized and generalized left ventricular contraction abnormalities. Am J Cardiol 1984;4:987-98.
16. Saxon LA, Kerwin WF, Cahalan MK, et al. Acute effects of intraoperative multisite ventricular pacing on left ventricular function and activation/contraction sequence in patients with depressed ventricular function. J Cardiovasc Electrophysiol 1998;9:13-21.
17. Kerwin WF, Botvinick EH, O'Connell JW, et al. Ventricular contraction abnormalities in dilated cardiomyopathy: effect of biventricular pacing to correct interventricular dyssynchrony. J Am Coll Cardiol 2000;35:1221-1227.
18. Hochleitner M, Hortnagl H, Hortnagl H, et al. Long-term efficacy of physiologic dual-chamber pacing in the treatment of end-stage idiopathic dilated cardiomyopathy. Am J Cardiol 1992;70:1320-1325.
19. Auricchio A, Sommariva L, Salo RW, et al. Improvement of cardiac function in patients with severe congestive heart failure and coronary artery disease by dual chamber pacing with shortened AV delay. Pacing Clin Electrophysiol 1993;16:2034-2043.
20. Shinbane JS, Chu E, DeMarco T, et al. Evaluation of acute dual-chamber pacing with a range of atrioventricular delays on cardiac performance in refractory heart failure. J Am Coll Cardiol 1997;30:1295-1300.
21. Gold MR, Feliciano Z, Gottlieb SS, et al. Dual-chamber pacing with short atrioventricular delay in congestive heart failure: a randomized study. J Am Coll Cardiol 1995;26:967-973.
22. Rosenqvist M, Isaaz K, Botvinick EH, et al. Relative importance of activation sequence compared to atrioventricular synchrony in left ventricular function. Am J Cardiol 1991;67:148-156.
23. Leclercq C, Gras D, Le Helloco A, et al. Hemodynamic importance of preserving the normal sequence of ventricular activation in permanent cardiac pacing. Am Heart J 1195;129:1133-1141.
24. Nishimura RA, Hayes DL, Holmes DR Jr, et al. Mechanisms of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction: an acute Doppler and catheterization hemodynamic study. J Am Coll Cardiol 1995;25:281-288.
25. Cazeau S, Ritter P, Backdach H, et al. Four chamber pacing in dilated cardiomyopathy. Pacing Clin Electrophysiol 1994;17:1974-1979.
26. Cazeau S, Ritter P, Lazarus A, et al. Multisite pacing for end-stage heart failure: early experience. Pacing Clin Electrophysiol 1996;19:1748-1757.
27. Foster AH, Gold MR, McLaughlin JS. Acute hemodynamic effects of atrio-biventricular pacing in humans. Ann Thorac Surg 1995;59:294-300.
28. Blanc JJ, Ettienne Y, Gilard M, et al. Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. Circulation 1997;96:3273-3277.
29. Auricchio A, Stellbrink C, Block M, et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. Circulation 1999;99:2993-3001.
30. Kass DA, Chen CH, Curry C, et al. Improved LV mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular delay. Circulation 1999;99:1567-1573.
31. Leclercq C, Cazeau S, LeBreton H, et al. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. J Am Coll Cardiol 1998;32:1825-1831.
32. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991;325:1468-1475.
33. Cohn JN, Goldstein SO, Greenberg BH, et al. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators. N Engl J Med 1998;339:1810-1816.
34. Auricchio A, Stellbrink C, Sack S, et al. The pacing therapies for congestive heart failure (PATH-CHF) study: rationale, design, and endpoints of a prospective randomized multicenter study. Am J Cardiol 1999 Mar 11;83:130D-135D.
35. Tei C, Nishimura RA, Seward JB, et al. Noninvasive Doppler-derived myocardia performance index: correlation with simultaneous measures of cardiac catheterization measurements. J Am Soc Echocardiogr 1997;10:169-178.
36. Dujardin KS, Tei C, Yeo TC, et al. Prognostic value of a Doppler index combining systolic and diastolic performance in idiopathic dilated cardiomyopathy. Am J Cardiol 1998;82:1071-1076.
37. Kerwin WF, Foster E, Paccanaro M, et al. Chronic biventricular pacing in dilated cardiomyopathy: improvements in myocardial performance correlate with Doppler measures of systolic function (abstract). Circulation 1999;100:1563.
38. Saxon LA, DeMarco T, Schafer J, et al; for the VIGOR Congestive Heart Failure Investigators. Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling. Circulation 2002;105:1304-1310.
39. Nelson GS, Berger RD, Fetics BJ, et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 2000;102:3053-3059.
40. Auricchio A, Stellbrink C, Sack S, et al. Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group. J Am Coll Cardiol 2002;39:2026-2033.
41. Gras D, Leclercq C, Tang AS, et al. Cardiac resynchronization therapy in advanced heart failure: the multicenter InSync clinical study. Eur J Heart Fail 2002;4:311-320.
42. Cazeau S, Leclercq C, Lavergne T, et al, for the Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators: Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001, 344:873-880.
43. Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002;40:111-118.
44. Abraham WT, Fisher WG, Smith AL, et al. for the MIRACLE study group. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-1853.
45. St. John Sutton MG, Plappert T, Abraham WT, et al. Cardiac resynchronization therapy results in left ventricular reverse remodeling: evidence from the MIRACLE trial (abstract). Circulation 2001;104(Supplement II):2918.
46. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implantable defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-1940.
47. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1567-1583.
48. Coletta A, Thackray S, Nikitin N, et al. Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP Trial, and HARDBALL. Eur J Heart Fail 2002;4:381-388.
49. Saxon LA, Boehmer JP, Hummel J, et al. Biventricular pacing in patients with congestive heart failure: two prospective randomized trials. The VIGOR CHF and VENTAK CHF Investigators. Am J Cardiol 1999;83:120-123.
50. Thackray S, Coletta A, Jones P, et al. Clinical trials update: highlights of the Scientific Sessions of Heart Failure 2001, a meeting of Working Group on Heart Failure of the European Society of Cardiology. CONTAK-CD, CHRISTMAS, OPTIME-CHF. Eur J Heart Fail. 2001;3:491-494.
51. CONTAK-CD/Ventak-CHF trials results. Press Release, Guidant Corporation. Available at: http://www.guidant.com/news/200/web_release/nr_000209.shtml Accessed May 2, 2001.
52. Bristow MR, Feldman AM, Saxon LA. Heart failure management using implantable devices for ventricular resynchronization: Comparison of medical therapy, pacing and defibrillation in chronic heart failure (COMPANION) trial, COMPANION steering committee and COMPANION Clinical Investigators. J of Cardiac Failure 2000;6:276-285.
53. COMPANION Trial (notification of study termination). Press Release, Guidant Corporation. Available at: http:/ www.guidant.com/news/200/print_release/companion-pr.pdf Accessed November 21, 2002.
54. Salukhe TZ, Francis DP, Sutton R. Comparison of medical therapy, pacing and defibrillation in heart failure (COMPANION) trial terminated early; combined biventricular pacemaker-defibrillators reduce all-cause mortality and hospitalization. Int J Cardiol 2003;87:119-120.
55. Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defivrillator: the dual chamber and VVI implantable defibrillator (DAVID) trial. JAMA 2002;288:3159-3161.
56. Moss AJ, Zareba W, Hall WJ, et al., For the Multicenter Automatic Defibrillator Implantation Trial II Investigators Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
57. Leclercq C, Victor F, Alonso C, et al. Comparative effects of permanent biventricular pacing for refractory heart failure in patients with stable sinus rhythm or chronic atrial fibrillation. Am J Cardiol 2000;85:1154-1156, A9.
58. Daubert JC, Ritter P, Le Breton H, et al. Permanent left ventricular pacing with transvenous leads inserted into the coronary veins. Pacing Clin Electrophysiol 1998;21:239-245.
59. Sack S, Heinzel F, Dagres N, et al. Stimulation of the left ventricle through the coronary sinus with a newly developed 'over the wire' lead system - early experience with lead handling and positioning. Europace 2001;3:317-323.
60. Butter C, Auricchio A, Stellbrink C, et al. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation 2001;104:3026-3029.
61. Alonso C, Leclerc C, d'Allonnes FR, et al. Six year experience of transvenous left ventricular lead implantation for permanent biventricular pacing in patients with advanced heart failure: technical aspects. Heart 2001;86:405-410.
62. Kara J, Quan H, Quan KJ, et al. Biventricular pacing for congestive heart failure: early experience in surgical epicardial versus coronary sinus lead placement. Heart Surg Forum 2002;6:E1-E6.